Alleviant Expands Leadership to Bring Brain-First Mental Health Care to More Communities
Founder Brian Mears to drive scientific advancement and outreach as new President Kyla Farler guides operational excellence during nationwide growth
LITTLE ROCK, AR – August 26 – Alleviant Integrated Mental Health, a national leader in brain-first, integrative psychiatric care, has announced a pivotal leadership transition designed to support the company’s rapid expansion and deepen its impact in advancing psychiatric science.
Founder and CEO Brian Mears, DNAP, APRN, CRNA, PMHNP-BC, who established Alleviant in 2017, will now focus his leadership on propelling the company’s national expansion, forging high-value strategic partnerships, and advancing the cutting-edge psychiatric and neurophysiological innovations that distinguish Alleviant in the field. Remaining as CEO, Mears will continue to provide visionary direction while spearheading the research and clinical advancements that shape the future of the company’s transformative care model.
To lead daily operations and oversee all aspects of company management, Kyla Farler has been promoted to the role of President. Farler, who has served as Alleviant’s Chief Financial Officer, brings a rare blend of legal, financial, and operational expertise. She is a licensed attorney, Certified Public Accountant, Certified Internal Auditor, Certified Fraud Examiner, and holds a Masters in Accounting and an MBA. Known for her exceptional skills in organizational management, policy development, and effective communication, Farler has been instrumental in guiding Alleviant through its most significant periods of growth.
“Kyla’s leadership, expertise, and unwavering commitment to our mission make her the ideal choice for President,” said Mears. “Her ability to combine strategic insight with operational precision ensures Alleviant will continue delivering world-class care while expanding our reach to communities nationwide.”
Farler’s appointment comes at a time of accelerated national growth for Alleviant, with new clinics opening across multiple states and continued investment in advanced treatment modalities, including qualitative EEG (qEEG) and NeuroSync™, the company’s personalized, multimodal brain optimization program.
“I am honored to step into the role of President during such an exciting chapter,” said Farler. “Alleviant’s mission of transforming mental health care through a brain-first, integrative approach is more important than ever. I look forward to working with our talented team to bring hope and healing to more patients across the country.”
Since its founding, Alleviant has pioneered a new standard in psychiatry, focusing on identifying and addressing the root causes of mental health conditions through objective brain diagnostics, evidence-based treatments, and compassionate care. Today, the company serves patients nationwide and continues to expand its footprint to meet growing demand.
About Alleviant Integrated Mental Health
Alleviant Integrated Mental Health is a national leader in brain-first, objective psychiatry, combining advanced outpatient neurodiagnostics, integrative treatment modalities, and compassionate, team-based care to address the root causes of mental health conditions. Founded in 2017, Alleviant operates clinics across the United States and is dedicated to advancing the science of psychiatry and neurophysiology.
